In addition, we confirmed that overexpression of PRMT5 rescued the decidualization defect of primary hEnSCs from endometriosis patients, suggesting that promotion of PRMT5 may provide novel therapeutic strategies for the treatment of decidualization defects in infertile women, such as those with endometriosis. This evidence concerns the gene PRMT5 and endometriosis.